Novel treatments are significantly reshaping the landscape regarding systemic disorders . MOTS-c, including several substances , offer fascinating avenues in addressing conditions like type 2 glucose intolerance and weight gain. Despite investigations are ongoing , initial data suggest impressive gains in glycemic control and physical reduction ,